Project Management

Project Management and Oversight (WP1)

Coordinator

Wan-Fai Ng

University of Newcastle upon Tyne

Co-Coordinator

Walter Maetzler

Universitätsklinikum Schleswig-Holstein

Project Lead

Nikolay Manyakov

Janssen Pharmaceutica NV

Project Co-Lead

Geert Van Gassen

Takeda Pharmaceuticals International AG

Project Manager

David Wenn

iXscient Ltd

Project Manager

Mike Jackson

iXscient Ltd

Industry Project Manager

Dario Masullo

Janssen Pharmaceutica NV

Clinical Knowledge and Insight (WP2)

Academic Lead

Walter Maetzler

Universitätsklinikum Schleswig-Holstein

Industry Lead

Babak Boroojerdi

UCB Biopharma SPRL

Digital Device and Technology (WP3)

Academic Lead

Christopher Bull

University of Newcastle upon Tyne

Industry Lead

Kenneth Mosca

Janssen Pharmaceutica NV

Device-specific Data Analytics and Performance Assessment (WP4)

Academic Lead

Teemu Ahmaniemi

Teknologian tutkimuskeskus VTT Oy

Industry Lead

Meenakshi Chatterjee

Janssen Pharmaceutica NV

Industry Co-Lead

Christoph Kanzler

Biogen IDEC Ltd

Data Management (WP5)

Academic Lead

Yi-Ke Guo

Imperial College of Science Technology and Medicine

Academic Co-Lead

Kai Sun

Imperial College of Science Technology and Medicine

Industry Lead

Frédéric Baribaud

Bristol-Myers Squibb Company Corp.

Clinical Study Organisation & Management (WP6)

Academic Lead

Wan-Fai Ng

University of Newcastle upon Tyne

Industry Co-Lead

Nadir Ammour

Sanofi Aventis Recherche et Développement

Study Sponsor

Walter Maetzler

Universitätsklinikum Schleswig-Holstein

Statistical Inference Design and Learning (WP7)

Academic Lead

Jérôme Kalifa

Let it Care SAS

Industry Lead

Stefan Avey

Janssen Pharmaceutica NV

Data Protection, Ethics and Legal Challenges (WP8)

Academic Lead

Evert-Ben van Veen

Stichting MLC Foundation

Industry Lead

Ann Marie Hake

Eli Lilly & Co Ltd.

Dissemination, Exploitation & Sustainability (WP9)

Academic Lead

Veli Stroetmann

empirica Gesellschaft für Kommunikations und Technologieforschung Mbh

Industry Lead

David Nobbs

F. Hoffmann-La Roche AG

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853981. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and PARKINSON’S DISEASE SOCIETY OF THE UNITED KINGDOM LBG.

Copyright 2024 IDEA-FAST